Similar articles

• Iron metabolism and chelation therapy in hemosiderosis.

  Graziano JH. Graziano JH. Curr Top Hematol. 1978;1:127-50. Curr Top Hematol. 1978. PMID: 400529 Review. No abstract available.
• Evaluation of continuous desferrioxamine administration in adults with transfusional hemosiderosis.

  Cooper B, Bunn HF, Propper RD, Nathan DG, Rosenthal DS, Moloney WC. Cooper B, et al. Trans Assoc Am Physicians. 1977;90:335-41. Trans Assoc Am Physicians. 1977. PMID: 611665 No abstract available.
• Iron metabolism and iron chelation in the thalassaemia disorders.

  Pippard MJ. Pippard MJ. Haematologica. 1990 Sep-Oct;75 Suppl 5:66-71. Haematologica. 1990. PMID: 2086383 Review. No abstract available.
• [Further experiences with iron-chelating therapy (desferrioxamine and ascorbic acid) in siderochromatosis and Cooley's disease].

  Cartei G, Cazzavillan M, Chisesi T, Battista R, Barbui T, Dini E. Cartei G, et al. Minerva Med. 1978 Mar 17;69(13):811-21. Minerva Med. 1978. PMID: 643223 Italian. No abstract available.
• Iron absorption in non-transfused iron loading anaemias: prediction of risk for iron loading, and response to iron chelation treatment, in beta thalassaemia intermedia and congenital sideroblastic anaemias.

  Pippard MJ, Weatherall DJ. Pippard MJ, et al. Haematologia (Budap). 1984;17(1):17-24. Haematologia (Budap). 1984. PMID: 6724353